SciDev.Net
Science and Development Network
News, views and information about science, technology and the developing world
Search Archive
Opinions archive results 1-20 of 27 in Health and Access to medicine
Cuba: The right to health during economic crises
The international community can help Cuba to keep on providing its population with accessible healthcare, even during economic turbulence, say Pol de Vos and Patrick Van der Stuyft.
OPINION | 9 November 2009 | ES
Biomed Analysis: Mothers' health needs targeted science
Maternal health needs a new, pragmatic, research-led approach targeted specifically for developing countries, says Priya Shetty.
South Africa needs an HIV/AIDS truth commission
A truth commission can account for South Africa's past HIV/AIDS denialist policies and rebuild trust, says AIDS expert, Salim S. Abdool Karim.
BioMed Analysis: Pooling patents for HIV drugs
A UNITAID patent pool could revolutionise HIV treatment and research in developing countries — if payment can be agreed, says Priya Shetty.
Home-grown vaccines are crucial for public health
Countries need to produce their own vaccines, and they need to invest in public sector capacity to do it, says Indian scientist Y. Madhavi.
OPINION | 23 September 2009 | EN
Funding mass treatment of lymphatic filariasis is vital
Interrupting funding for mass treatment of lymphatic filariasis can lead to a quick resurgence in the disease, say Kimberly Won and colleagues.
OPINION | 6 September 2009 | EN
All countries deserve equal access to pandemic vaccines
Swine flu vaccines should be equally available, regardless of a country's ability to pay, says medical expert Tadataka Yamada.
OPINION | 18 August 2009 | EN
How to fill the gaps in global clinical research networks
Policymakers must think outside the box to strengthen clinical research networks for global health, says Harvard researcher Jeff Blander.
OPINION | 22 July 2009 | EN
Can early therapy prevent HIV?
More research is needed on how to tackle HIV with antiretroviral therapy, say Kevin M De Cock and colleagues at the WHO.
OPINION | 17 July 2009 | EN
'Lack of political will' to develop new vaccines
A lack of political will to create vaccines is causing millions of deaths a year due to infectious diseases, says Manuel Elkin Patarroyo.
OPINION | 28 May 2009 | ES
New tools to fight fake medicines
New technologies can help African countries identify counterfeit or substandard drugs, says director of Africa Fighting Malaria Roger Bate.
Will Glaxo's big plans really benefit the poor?
GlaxoSmithKline plans to cut medicine prices and create a 'patent pool' — but does any of this reflect a real drive to boost the health of the poor?
OPINION | 6 March 2009 | EN
Eliminating lymphatic filariasis: We're not there yet
While progress has been made in tackling lymphatic filariasis, we are still long way from eliminating the disease, says David H. Molyneux.
Priority review vouchers might not be the way forward
FDA priority review vouchers will not necessarily encourage research into tropical diseases, argues Aaron Kesselheim.
Africa ill-equipped for fight against cancer
African governments are ill-prepared to address the continent's growing cancer burden, warn Hany Besadaand and Vadim Ermakov.
OPINION | 11 September 2008 | EN
Mental health in the developing world: time for innovative thinking
Developing nations must stop aping the North's mental health services and use strategies tailored to their own needs, says Vikram Patel.
Surgery is cheap and effective, but donors neglect it
Doruk Ozgediz and Robert Riviello make the case for devoting more resources to easily treated surgical conditions in Africa.
OPINION | 10 June 2008 | EN
Stable funding system needed for neglected diseases
Peter J. Hotez believes the establishment of a new financing mechanism is vital for the control and eradication of neglected diseases.
Drug development: litigate less, innovate more
Drug companies seeking to promote research and development in poor nations should focus on innovation, not legislation, argues Angela Saini.
Vaccine research needs to cover all bases
To address the urgency of the HIV crisis, says Mauro Schechter, vaccine researchers must pursue clinical trials as well as basic science, testing vaccines for both prevention and therapy.
OPINION | 20 July 2005 | EN
Information Services
Missed the Global Health Forum 2009?
Our blog, by SciDev.Net columnist Priya Shetty, will fill you in, as will our interview with the Global Forum's Gill Samuels
